Abstract:Introduction Peritoneal dialysis (PD) is recognized as an effective treatment for patients with end-stage renal failure. Conventional PD solutions are unphysiological, as they contain bio-incompatible concentrations of glucose to provide the osmotic drive (Popovich et al. 1978) Thus, with increasing duration on PD, the peritoneum undergoes progressive structural and functional deterioration. Diabetiform alterations of the peritoneum, for example, the reduplication of the basement membrane, and increased matrix accumulation and deposition within the submesothelium are commonly observed in PD patients. These changes are mediated in part through activation of PKC and induction of TGF-β1 (Ha et al. 2001). Emodin (3-methyl-1,6,8 trihydroxyanthraquinone) has previously been demonstrated to reduce cell proliferation and fibronectin synthesis in cultured mesangial cells (Kuo et al. 2001; Yao et al. 1994). How emodin modulates glucose-induced fibronectin synthesis in human peritoneal mesothelial cells (HPMCs) has not been elucidated and thus constitutes the aim of this study. Materials and methods Confluent growth-arrested HPMCs were cultured under physiological (5 mm) or elevated (30 mm) d-glucose concentrations in the presence or absence of emodin (20 µg/ml) for periods up to 72 h. PKC-α activation in HPMCs cultured under control and experimental conditions was determined by Western blot analysis of cytosolic and cell membrane extracts. Synthesis of fibronectin and TGF-β1 was investigated by a combination of ELISAs, immunohistochemistry and Western blot analysis. Mannitol was used as the hexose control. Results Exposure of HPMCs to 30 mm d-glucose resulted in the activation of PKC-α commencing 12 h after stimulation, as demonstrated by the translocation of PKC-α from the cytosol to the cell membrane. Maximum induction of PKC-α was observed 48 h after stimulation and increased 1.4-fold and 3.7-fold in the cytosolic and membrane fractions, respectively, compared to 5 mm d-glucose. Activation of PKC-α was accompanied by the induction of TGF-β1 secretion in a time-dependent manner (3.72 ± 0.29 and 4.30 ± 0.50 pg/µg cellular protein at 24 h and 48 h, respectively, for 30 mm d-glucose compared to 2.13 ± 0.23 and 2.65 ± 0.32 pg/µg cellular protein at 24 h and 48 h, respectively, for 5 mm d-glucose, P < 0.001 at both time points) and increased fibronectin synthesis. Whilst emodin had no effect on constitutive PKC-α, TGF-β1 or fibronectin synthesis, emodin abrogated elevated glucose stimulation of PKC-α, and decreased TGF-β1 secretion and fibronectin synthesis to basal levels. Discussion Our findings demonstrate that emodin can ameliorate the undesirable effects of concentrated glucose on HPMCs through the suppression of PKC-α activation. This study suggests that emodin may have therapeutic potential in the prevention or treatment of glucose-induced structural and functional abnormalities in the peritoneal membrane.

Protein Kinase C Α Inhibition Prevents Peritoneal Damage in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate

Protein kinase C beta deficiency increases glucose-mediated peritoneal damage via M1 macrophage polarization and up-regulation of mesothelial protein kinase C alpha.

Inhibiting PKCβ2 protects HK-2 cells against meglumine diatrizoate and AGEs-induced apoptosis and autophagy.

Advanced Glycation End Products Facilitate Proliferation and Reduce Early Apoptosis of Cardiac Microvascular Endothelial Cell Via PKCβ Signaling Pathway: Insight from Diabetic Cardiomyopathy

The Peritoneal Surface Proteome in a Model of Chronic Peritoneal Dialysis Reveals Mechanisms of Membrane Damage and Preservation

Glucose-induced pseudohypoxia and advanced glycosylation end products explain peritoneal damage in long-term peritoneal dialysis

Disruption of Low Density Lipoprotein Receptor Pathway is Involved in Peritoneal Fibrosis Induced by High Glucose Peritoneal Dialysis Solution

SGLT2 inhibition by intraperitoneal dapagliflozin mitigates peritoneal fibrosis and ultrafiltration failure in a mouse model of chronic peritoneal exposure to high-glucose dialysate

Inhibition of PI3K/AKT/mTOR Signalling Pathway Activates Autophagy and Suppresses Peritoneal Fibrosis in the Process of Peritoneal Dialysis

Beta-Catenin Participates in Dialysate-Induced Peritoneal Fibrosis Via Enhanced Peritoneal Cell Epithelialto-Mesenchymal Transition

Autophagy Promotes Fibrosis and Apoptosis in the Peritoneum During Long-Term Peritoneal Dialysis

Macrophages Regulates the Transition of Pericyte to Peritoneal Fibrosis Through the GSDMD/IL-1β Axis

Aryl Hydrocarbon Receptor Pathway Augments Peritoneal Fibrosis in a Murine CKD Model Exposed to Peritoneal Dialysate

Emodin ameliorates glucose-induced fibronectin synthesis in human peritoneal mesothelial cells by inhibiting PKC-α activation

Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization

1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice

High glucose contributes to the polarization of peritoneal macrophages to the M2 phenotype in vivo and in vitro

Glucose Induces ER Stress Response-Mediated Peritoneal Mesothelial Cell Death

Cumulative Dialytic Glucose Exposure is a Risk Factor for Peritoneal Fibrosis and Angiogenesis in Pediatric Patients Undergoing Peritoneal Dialysis Using Neutral-pH Fluids

Emodin Ameliorates Glucose-Induced Morphologic Abnormalities and Synthesis of Transforming Growth Factor Beta 1 and Fibronectin by Human Peritoneal Mesothelial Cells

PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease